A new state-of-the-art robotic surgical system is helping doctors at St. Agnes Medical Cancer detect lung cancer in its earlier stages.

A recently-approved treatment could take a BiTE out of small cell lung cancer by using a person's own body to fight back.

Small cell lung cancer, or SCLC, is aggressive, lethal and particularly cruel because chemotherapy initially works so well. But within just a few months, SCLC becomes resistant to drugs and dashes ...

The "cell of origin" of the second most common lung cancer and the way that it becomes dominant in the lung have been discovered in a new study in mice and humans by researchers at UCL ...

They found that while only 17-18% of eligible individuals received lung cancer screening, 65% of those eligible received breast and colorectal cancer screening -- a nearly 4-fold higher rate.

Among eligible populations, screening for breast and colorectal cancers was nearly four times more common than for lung cancer. Among those who never had lung cancer screening, roughly 60% had ...

Pinar Uysal-Onganer does not work for, consult, own shares in or receive funding from any company or organization that would benefit from this article, and has disclosed no relevant affiliations ...

How Does Libtayo Work for Non-Small-Cell Lung Cancer (NSCLC)? Libtayo is a specific kind of medicine called immunotherapy. Immunotherapies work by helping your body’s own immune system work to ...

About 80% of people who have lung cancer have non-small-cell lung cancer. NSCLC usually spreads more slowly than small-cell lung cancers. Both cancers affect the lungs and have similar symptoms ...

Small cell lung cancer is one of the most aggressive types of cancer. It represents about 10 to 15% of all lung cancer cases in the United States, with roughly 30,000 to 35,000 new cases each year.